$Evaluating the antifracture efficacy of bisphosphonates.$

Evaluating the antifracture efficacy of bisphosphonates.

Oral bisphosphonate dosing schedules have evolved from the original daily regimens to weekly (alendronate and risedronate) and monthly (risedronate and ibandronate) regimens. Intravenous (i.v.) bisphosphonates are administered less frequently-quarterly ibandronate injection and yearly zoledronic aci...

書誌詳細
主要な著者:	Pazianas, M, Epstein, S, Zaidi, M
フォーマット:	Journal article
言語:	English
出版事項:	2009

類似資料

Antifracture agents for prostate cancer patients on androgen deprivation therapy
著者:: Bhupendra P Singh, 等
出版事項: (2010-01-01)

The sequential antifracturative treatment: a meta-analysis of randomized clinical trials
著者:: Angelo Fassio, 等
出版事項: (2024-04-01)

Safety of bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2011)

Bisphosphonates and bone quality.
著者:: Pazianas, M, 等
出版事項: (2014)

Atrial fibrillation and bisphosphonate therapy.
著者:: Pazianas, M, 等
出版事項: (2010)

Potential therapeutic effects of oral bisphosphonates on the intestine.
著者:: Pazianas, M, 等
出版事項: (2011)

Safety issues with bisphosphonate therapy for osteoporosis.
著者:: Suresh, E, 等
出版事項: (2014)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
著者:: Pazianas, M
出版事項: (2013)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
著者:: Alexander J Rodríguez, 等
出版事項: (2022-06-01)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
著者:: Alexander J Rodríguez, 等
出版事項: (2021-07-01)

Bisphosphonates and colon cancer: reply.
著者:: Pazianas, M, 等
出版事項: (2013)

Bisphosphonates and colon cancer: Reply
著者:: Pazianas, M, 等
出版事項: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates
著者:: Pazianas M, 等
出版事項: (2013-10-01)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
著者:: Michael Pazianas
出版事項: (2021-08-01)

Atrial fibrillation and the use of oral bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2011)

Atrial fibrillation and the use of oral bisphosphonates
著者:: Michael Pazianas, 等
出版事項: (2011-03-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
著者:: Pazianas, M, 等
出版事項: (2010)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
著者:: Abrahamsen, B, 等
出版事項: (2013)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
著者:: Pazianas, M, 等
出版事項: (2010)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
著者:: Pazianas, M, 等
出版事項: (2014)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
著者:: Pazianas, M, 等
出版事項: (2008)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: Reply to Yarom and Elad
著者:: Pazianas, M, 等
出版事項: (2008)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
著者:: Pazianas, M, 等
出版事項: (2007)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
著者:: Garriga, C, 等
出版事項: (2018)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
著者:: Pazianas, M, 等
出版事項: (2012)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
著者:: Pazianas, M, 等
出版事項: (2013)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
著者:: Garriga, C, 等
出版事項: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
著者:: Garriga, C, 等
出版事項: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
著者:: Garriga, C, 等
出版事項: (2017)

Bisphosphonates
著者:: Bishop, N, 等
出版事項: (2013)

Bisphosphonates
著者:: Fırat Öztürk
出版事項: (2009-04-01)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
著者:: Russell, R, 等
出版事項: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
著者:: Russell, R, 等
出版事項: (2007)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
著者:: Sujata Sharma, 等
出版事項: (2023-04-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
著者:: İlke Coşkun Benlidayı, 等
出版事項: (2015-08-01)

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
著者:: Russell, R, 等
出版事項: (2008)

Bisphosphonates: An update
著者:: Nalliappan Ganapathy, 等
出版事項: (2012-01-01)

Bisphosphonates 2006
著者:: Russell, R
出版事項: (2006)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
著者:: Pazianas, M, 等
出版事項: (2012)